secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0000950170-24-069895
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

RxSight shareholders re-elect three Class III directors, approve say-on-pay, one-year frequency, and E&Y ratification
--------------------------------------------------------------------------------

- Three Class III directors re-elected: Julie B. Andrews, Robert J. Palmisano, Tamara R. Fountain.
- Say-on-pay approved: 22.6M for, 1.1M against, 0.4M abstain.
- Advisory vote on frequency: one-year option favored with 20.5M votes; company will hold annual say-on-pay.
- Ratification of Ernst & Young as independent auditor for FY 2024: 29.9M for, 46k against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017024069895/0000950170-24-069895-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017024069895/rxst-20240606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-069895

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer